-+ 0.00%
-+ 0.00%
-+ 0.00%

Biodesix Raises FY2026 Sales Guidance from $106.000M-$112.000M to $108.000M-$114.000M vs $108.680M Est

Benzinga·05/04/2026 20:02:30
Listen to the news
Biodesix (NASDAQ:BDSX) raises FY2026 sales outlook from $106.000 million-$112.000 million to $108.000 million-$114.000 million vs $108.680 million estimate.